Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Director | May 21, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date May 21, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock - Held in my name or my wife's nameSEC Table I · non-derivative | Direct | 205,760 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Sale · Disposed 7,500 · Balance 205,760 |
| Option to Purchase Common Stock [2022 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $69.19 · Expires 2027-05-04 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 7,500 |
| Option to Purchase Common Stock [2023 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $55.75 · Expires 2028-05-03 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 7,500 |
| Option to Purchase Common Stock [2024 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $96.03 · Expires 2029-05-08 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 7,500 |
| Option to Purchase Common Stock [2025 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $94.66 · Expires 2030-05-07 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 7,500 |
| Option to Purchase Common Stock [2026 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $171.42 · Expires 2031-05-06 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 7,500 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 22, 2026 20:07 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleCommon Stock - Held in my name or my wife's name | 7,500 | $195.14 | $1,463,565.75 |
DisclosureSEC source: 0001437749-26-018248 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,760 Read SEC document |
| May 07, 2026 Filed May 7, 2026 22:01 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2026 Grant] · Derivative | 7,500 | $0.00 Strike: $171.42 | $0.00 |
DisclosureSEC source: 0001437749-26-015687 · rdgdoc.xml · derivative · entry 6 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-05-06 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2026 Filed May 6, 2026 20:10 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2021 Grant] · Derivative | 7,500 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001437749-26-015203 · rdgdoc.xml · derivative · entry 2 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2026-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2026 Filed May 6, 2026 20:10 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock - Held in my name or my wife's name | 7,500 | $71.64 | $537,300.00 |
DisclosureSEC source: 0001437749-26-015203 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 16:02 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock - Held in my name or my wife's name | 152 | $104.69 | $15,912.88 |
DisclosureSEC source: 0001437749-25-019486 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,760 Read SEC document |
| May 08, 2025 Filed May 9, 2025 20:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2025 Grant] · Derivative | 7,500 | $0.00 Strike: $94.66 | $0.00 |
DisclosureSEC source: 0001437749-25-015787 · rdgdoc.xml · derivative · entry 10 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2030-05-07 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 8, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:37 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2020 Grant] · Derivative | 5,000 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-25-015145 · rdgdoc.xml · derivative · entry 6 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:37 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock (held in my name or my wife's name) | 5,000 | $64.64 | $323,200.00 |
DisclosureSEC source: 0001437749-25-015145 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 09, 2024 Filed May 13, 2024 21:34 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2024 Grant] · Derivative | 7,500 | $0.00 Strike: $96.03 | $0.00 |
DisclosureSEC source: 0001437749-24-016312 · rdgdoc.xml · derivative · entry 10 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-05-08 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 9, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 30, 2024 Filed May 1, 2024 20:40 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2019 Grant] · Derivative | 3,500 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-24-014187 · rdgdoc.xml · derivative · entry 9 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 30, 2024 Filed May 1, 2024 20:40 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2019 Grant] · Derivative | 4,000 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-24-014187 · rdgdoc.xml · derivative · entry 8 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 7,500 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 30, 2024 Filed May 1, 2024 20:40 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock (held in my name or my wife's name) | 3,001 | $90.87 | $272,700.87 |
DisclosureSEC source: 0001437749-24-014187 · rdgdoc.xml · nonDerivative · entry 3 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,912 F3 · shares: Shares were withheld by the Company to pay the exercise price. F4 · balance_after: Total amount for this title following transactions reported on this form. Read SEC document |
| April 30, 2024 Filed May 1, 2024 20:40 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock (held in my name or my wife's name) | 3,500 | $77.92 | $272,720.00 |
DisclosureSEC source: 0001437749-24-014187 · rdgdoc.xml · nonDerivative · entry 2 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · balance_after: Transaction totaled on the line below for securities of this title. Read SEC document |
| April 30, 2024 Filed May 1, 2024 20:40 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock (held in my name or my wife's name) | 4,000 | $77.92 | $311,680.00 |
DisclosureSEC source: 0001437749-24-014187 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · balance_after: Transaction totaled on the line below for securities of this title. Read SEC document |
| December 04, 2023 Filed Dec 11, 2023 21:36 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock - Fam. Partnership (LR Ent.) | 3,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034082 · rdgdoc.xml · nonDerivative · entry 4 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Read SEC document |
| June 29, 2023 Filed Jul 3, 2023 20:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | PurchaseCommon Stock (held in my name or my wife's name) | 2,100 | $61.40 | $128,944.20 |
DisclosureSEC source: 0001437749-23-019239 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,413 Read SEC document |
| May 04, 2023 Filed May 4, 2023 22:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2023 Grant] · Derivative | 7,500 | $0.00 Strike: $55.75 | $0.00 |
DisclosureSEC source: 0001437749-23-012623 · rdgdoc.xml · derivative · entry 10 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-05-03 F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:56 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011337 · rdgdoc.xml · derivative · entry 11 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F5 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:56 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-22-011337 · rdgdoc.xml · derivative · entry 9 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:56 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-22-011337 · rdgdoc.xml · derivative · entry 7 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:56 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock - Held in my name or my wife's name | 2,500 | $64.64 | $161,600.00 |
DisclosureSEC source: 0001437749-22-011337 · rdgdoc.xml · nonDerivative · entry 2 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F4 · balance_after: Total amount of shares beneficially owned following transactions reported for this "Title of Securities" on this form. Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:56 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock - Held in my name or my wife's name | 2,500 | $61.90 | $154,750.00 |
DisclosureSEC source: 0001437749-22-011337 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · balance_after: Transactions for this "Title of Security" totaled on the line below. Read SEC document |
| December 30, 2021 Filed Jan 12, 2022 22:02 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock - Held in my name or my wife's name | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-000814 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,313 Read SEC document |
| December 29, 2021 Filed Dec 29, 2021 20:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-21-029394 · rdgdoc.xml · derivative · entry 6 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 29, 2021 Filed Dec 29, 2021 20:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock - Held in my name or my wife's name | 5,000 | $61.90 | $309,500.00 |
DisclosureSEC source: 0001437749-21-029394 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 06, 2021 Filed May 7, 2021 19:55 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001437749-21-011330 · rdgdoc.xml · derivative · entry 9 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-05 F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 27, 2021 Filed Apr 30, 2021 15:01 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $62.78 | $0.00 |
DisclosureSEC source: 0001437749-21-010360 · rdgdoc.xml · derivative · entry 5 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2021 Filed Apr 30, 2021 15:01 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock - Held in my name or my wife's name | 7,500 | $62.78 | $470,850.00 |
DisclosureSEC source: 0001437749-21-010360 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on June 2, 2016. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 14:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | PurchaseCommon Stock - Family LP (BFLP) | 477 | $60.93 | $29,062.18 |
DisclosureSEC source: 0001437749-20-020152 · rdgdoc.xml · nonDerivative · entry 2 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · General Partner Disclosed balance after: 30,000 Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-20-010096 · rdgdoc.xml · derivative · entry 9 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 20:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $61.25 | $0.00 |
DisclosureSEC source: 0001437749-20-007324 · rdgdoc.xml · derivative · entry 6 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 20:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock - Held in my name or my wife's name | 4,407 | $75.86 | $334,315.02 |
DisclosureSEC source: 0001437749-20-007324 · rdgdoc.xml · nonDerivative · entry 2 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,813 F2 · shares: Shares were withheld by the Company to pay the exercise price. F3 · balance_after: Total of this "Common Stock - Held in my name or my wife's name" security following transactions reported on this form. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 20:21 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock - Held in my name or my wife's name | 7,500 | $61.25 | $459,375.00 |
DisclosureSEC source: 0001437749-20-007324 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 7, 2015. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 31, 2019 Filed Feb 6, 2020 23:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock - Held in my name or my wife's name | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-001934 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,720 Read SEC document |
| May 09, 2019 Filed May 10, 2019 20:47 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-19-009506 · rdgdoc.xml · derivative · entry 9 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2024-05-08 F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 03, 2019 Filed May 6, 2019 21:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $52.93 | $0.00 |
DisclosureSEC source: 0001437749-19-008869 · rdgdoc.xml · derivative · entry 5 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2019-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2019 Filed May 6, 2019 21:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock - Held in my name or my wife's name | 7,500 | $52.93 | $396,975.00 |
DisclosureSEC source: 0001437749-19-008869 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2005 Stock Option Plan on May 8, 2014. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 15:52 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock - Held in my name or my wife's name | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-000024 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,720 Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.90 | Not disclosed |
DisclosureSEC source: 0001437749-18-020632 · rdgdoc.xml · derivative · entry 14 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.90 | Not disclosed |
DisclosureSEC source: 0001437749-18-020632 · rdgdoc.xml · derivative · entry 13 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $72.94 | Not disclosed |
DisclosureSEC source: 0001437749-18-020632 · rdgdoc.xml · derivative · entry 12 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $72.94 | Not disclosed |
DisclosureSEC source: 0001437749-18-020632 · rdgdoc.xml · derivative · entry 11 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $62.78 | Not disclosed |
DisclosureSEC source: 0001437749-18-020632 · rdgdoc.xml · derivative · entry 10 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $62.78 | Not disclosed |
DisclosureSEC source: 0001437749-18-020632 · rdgdoc.xml · derivative · entry 9 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.25 | Not disclosed |
DisclosureSEC source: 0001437749-18-020632 · rdgdoc.xml · derivative · entry 8 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2020-05-06 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.25 | Not disclosed |
DisclosureSEC source: 0001437749-18-020632 · rdgdoc.xml · derivative · entry 7 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2020-05-06 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $52.93 | Not disclosed |
DisclosureSEC source: 0001437749-18-020632 · rdgdoc.xml · derivative · entry 6 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2019-05-07 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $52.93 | Not disclosed |
DisclosureSEC source: 0001437749-18-020632 · rdgdoc.xml · derivative · entry 5 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2019-05-07 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 03, 2018 Filed May 4, 2018 18:06 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-18-008656 · rdgdoc.xml · derivative · entry 9 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 15:55 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $47.45 | $0.00 |
DisclosureSEC source: 0001437749-18-005289 · rdgdoc.xml · derivative · entry 5 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2018-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.